Influence of topically and systemically active steroids on circulating leukocytes in Crohn's disease

American Journal of Gastroenterology

Volumn 93, Issue 10, 1998, Pages 1848-1853

  Tillinger, W ^b   Gasche, Christoph ^a   Reinisch, W ^b   Lichtenberger, C ^b   Bakos, S ^b   Dejaco, C ^b   Moser, G ^b   Vogelsang, H ^b   Gangl, A ^b   Lochs, H ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUDENOFALK; BUDESONIDE; C REACTIVE PROTEIN; CD64 ANTIGEN; CD71 ANTIGEN; CELL ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; METHYLPREDNISOLONE; OROSOMUCOID; STEROID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; MALE; MONONUCLEAR CELL; NEUTROPHIL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE; TOPICAL DRUG ADMINISTRATION;

ADULT; ANTI-INFLAMMATORY AGENTS; BUDESONIDE; CROHN DISEASE; CYTOKINES; DOUBLE-BLIND METHOD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LEUKOCYTES; LYMPHOCYTE ACTIVATION; MALE; METHYLPREDNISOLONE; NEUTROPHILS;

EID: 0032446962     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.536_e.x     Document Type: Article

References (31)

1. 1. Summers RW, Switz DM, Sessions JT Jr, et al. National Cooperative Crohn's Disease Study: Results of drug treatment. Gastroenterology 1979;77:847-69.
2. 2. Malchow H, Ewe K, Brandes JW, et al. European Cooperative Crohn's Disease Study (ECCDS): Results of drug treatment. Gastroenterology 1984:86:249-66.
3. 3. Rutgeerts P, Löfberg R, Malchow H, et al. A comparison of budesonide with prednisolone for active Crohn's disease. N Engl J Med 1994;331:842-5.
4. 4. Greenberg GR, Feagan BG, Martin F, et al. Oral budesonide for active Crohn's disease. N Engl J Med 1994;331:836-41.
5. 5. Sachar DB. Budesonide for inflammatory bowel disease. Is it a magic bullet? N Engl J Med 1994;873-4 (editorial).
6. 6. Pallone F, Fais S, Squarcia O, et al. Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens. Gut 1987;28:745-53.
7. 7. Raedler A, Fraenkel S, Klose K, et al. Involvement of the immune system in the pathogenesis of Crohn's disease. Gastroenterology 1985; 88:978-83.
8. 8. Senju M, Hulstaert F, Lowder J, Jewell DP. Flow cytometric analysis of peripheral blood lymphocytes in ulcerative colitis and Crohn's disease. Gut 1991;32:779-83.
9. 9. Mueller C, Knoflach P, Zielinski CC. T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and supernatants of stimulated peripheral blood mononuclear cells. Gastroenterology 1993;104:448-58.
10. 10. Saverymuttu SH, Peters AM, Crofton ME, et al. 111Indium autologous granulocytes in the detection of inflammatory bowel disease. Gut 1985;26:955-60.
11. 11. Scholmerich J, Schmidt E, Schümichen C, et al. Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium 99m-hexamethyl propylene amine oxine as leucocyte label. Gastroenterology 1989;95:1287-93.
12. 12. McCarthy DA, Rampton DS, Liu YC. Peripheral blood neutrophils in inflammatory bowel disease: Morphological evidence of in vivo activation in active disease. Clin Exp Immunol 1991;86:489-93.
13. 13. Cason J, Ainley CC, Wolstencroft RA, Thompson RPH. Polymorphonuclear leucocytes in Crohn's disease and ulcerative proctocolitis: Association between enhanced adherence to nylon fibers and disease variables. J Clin Path 1988;41:241-6.
14. 14. Nielsen OH, Ahnfeldt-Ronne I, Elmgreen J. Abnormal metabolism of arachidonic acid in chronic inflammatory bowel disease: Enhanced release of leucotriene B4 from activated neutrophils. Gut 1987;28: 181-5.
15. 15. Reinisch W, Gasche C, Lichtenberger C, et al. Altered expression of Fcg-receptors on circulating polymorphonuclear leucocytes in active Crohn's disease. Gastroenterology 1995;108:A901.
16. 16. Perussia B, Kobayashi M, Rossi ME, et al. Immune interferon enhances functional properties of human granulocytes: Role of Fc receptors and effect of lymphotoxin, tumor necrosis factor, and granulocyte-macrophage colony-stimulating factor. J Immunol 1987;138:765-74.
17. 17. Buckle AM, Hogg N. The effect of IFN-γ and colony-stimulating factors on the expression of neutrophil cell membrane receptors. J Immunol 1989;143:2295-2301.
18. 18. Petroni KC, Shen L, Guyre PM. Modulation of human polymorphonuclear leukocyte IgG Fc receptors and Fc receptor-mediated functions by IFN-γ and glucocorticoids. J Immunol 1988;140:3467-72.
19. 19. Sartor RB. Cytokines in intestinal inflammation: Pathophysiological and clinical considerations. Gastroenterology 1994;106:533-9.
20. 20. van Dulleman HM, van Deventer SJH, Hommes DW, et al. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995;109:129-35.
21. 21. Nakamura M, Saito H, Kasanuki J, et al. Cytokine production in patients with inflammatory bowel disease. Gut 1992;33:933-7.
22. 22. Mazlam MZ, Hodgson HJF. Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease. Gut 1992;33:773-8.
23. 23. Maeda M, Watanabe N, Neda H, et al. Serum tumor necrosis factor activity in inflammatory bowel disease. Immunopharmical Immunotoxical 1992;14:451-61.
24. 24. Best WR, Becktel JM, Singleton JW, Kern F. Development of a Crohn's disease activity index. Gastroenterology 1976;70:439-44.
25. 25. Gross V, Andus T, Caesar I, et al. and the German/Austrian Budesonide Study Group. Oral ph-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. Europ J Gastoenterol Hepatol 1996;8:905-9.
26. 26. Boumpas TB, Anastassiou ED, Older SA, et al. Dexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription. J Clin Invest 1991; 87:1739-47.
27. 27. Paliogianni F, Raptis A, Ahuja SS, et al. Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-AT. J Clin Invest 1993;91:1481-9.
28. 28. Lamas M, Sanz E, Martin-Parras, et al. Glucocorticoid hormones upregulate interleukin 2 receptor gene expression. Cell Immunol 1993; 151:437-50.
29. 29. Weiss G, Wachter H, Fuchs D. Linkage of cell-mediated immunity to iron metabolism. Immunol Today 1995;16:495-500.
30. 30. Gasche C, Reinisch W, Lochs H, et al. Anemia in Crohn's disease. Importance of inadequate erythropoietin production and iron deficiency. Dig Dis Sci 1994;39:1930-4.
31. 31. Van de Winkel JGJ, Anderson CL. Biology of human immunoglobin G Fc receptors. J Leukoc Biol 1991;49:511-24.